Skip to content

Multicenter clinical trial to evaluate the safety and feasibility of allogeneic tissue engineered product (human nanostructured artificial cornea) in patients with advanced corneal trophic ulcers refractory to (ophtalmic) conventional treatment.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515481-13-00
Acronym
CAH/Ulc/2010
Enrollment
20
Registered
2024-07-05
Start date
2024-07-05
Completion date
Unknown
Last updated
2024-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal trophic ulcers refractory to conventional treatment or sequelae of previous ulcers (such as stromal thinning or fibrosis), associated or not with limbal insufficiency of the same eye.

Brief summary

Incidence of adverse events and severe adverse events related with the IMP., Graft conditions (artificial cornea): integrity, graft survival or reabsorption., Local, regional or systemic infection signs., Induced corneal vascularization.

Detailed description

Ulcer persistence or regeneration of corneal stroma., Visual acuity., Corneal transparency., Quality of life (EQ5, part I and II)., Characterization of corneal surface (impression citology & OCT mapping).

Interventions

Sponsors

Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Incidence of adverse events and severe adverse events related with the IMP., Graft conditions (artificial cornea): integrity, graft survival or reabsorption., Local, regional or systemic infection signs., Induced corneal vascularization.

Secondary

MeasureTime frame
Ulcer persistence or regeneration of corneal stroma., Visual acuity., Corneal transparency., Quality of life (EQ5, part I and II)., Characterization of corneal surface (impression citology & OCT mapping).

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026